On methods to utilize HIV-RNA data measured by two different PCR assays.

Area of Science:

• Clinical Virology
• Biostatistics
• Pharmacometrics

Background:

• Plasma HIV-RNA levels are critical for evaluating antiretroviral therapy efficacy in HIV-infected patients.
• Polymerase chain reaction (PCR) assays measure HIV-RNA, but have limits of quantification (LoQ), leading to censored data below the LoQ.
• Standard and Ultrasensitive assays have different LoQs, complicating the analysis of HIV-RNA changes from baseline.

Purpose of the Study:

• To address the loss of information and potential bias in analyzing HIV-RNA data with censored values below the LoQ.
• To propose a simple imputation approach that accounts for the differing variability of standard and ultrasensitive HIV-RNA assays.
• To provide a statistically sound method for utilizing all available HIV-RNA data in clinical trials.

Main Methods:

• A novel, simple imputation approach is proposed to handle HIV-RNA values below the lower limit of quantification.
• The proposed method accounts for the distinct assay variability between standard and ultrasensitive PCR assays.
• A simulation study was conducted to compare the proposed imputation method against conventional and naive approaches.

Main Results:

• Conventional methods using only standard assay data may lead to information loss.
• Naive imputation replacing censored values can introduce bias due to differing assay variability.
• The proposed imputation method offers a statistically sound and practical solution for analyzing HIV-RNA data.

Conclusions:

• The proposed simple imputation approach effectively utilizes data from both standard and ultrasensitive HIV-RNA assays.
• This method provides a more accurate estimation of treatment efficacy by overcoming limitations of existing statistical techniques.
• The approach is illustrated with an example from an HIV clinical trial, demonstrating its practical applicability.